Funding for this research was provided by:
Uganda Research Training Collaboration, University of Minnesota (1)
Received: 27 February 2020
Accepted: 3 May 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: The study protocol and tool were approved by the Makerere University School of Medicine Research and Ethics Committee (SOMREC), the ethics committees of the participating hospitals, the Uganda National Council of Science and Technology (UNCST) (study number: HS122ES), and the University of Minnesota institutional review board. Study participants provided written informed consent before study measurements were taken, and all participants received transport and airtime reimbursement.
: All the authors have agreed to have this work published.
: K. Kunisaki reports consultancies with GlaxoSmithKline and Nuvaira, Inc. The other authors declare no competing interests